+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Nasopharyngeal Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Viral and Non-Viral Vector Manufacturing Market Report 2025 - Product Thumbnail Image

Viral and Non-Viral Vector Manufacturing Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Recombinant DNA Technology Market Report 2025 - Product Thumbnail Image

Recombinant DNA Technology Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Targeted Therapy Market Report 2025 - Product Thumbnail Image

Targeted Therapy Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Solid Tumor Cancer Treatment Market Report 2025 - Product Thumbnail Image

Solid Tumor Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Chronic Kidney Disease - Competitive Landscape, 2026 - Product Thumbnail Image

Chronic Kidney Disease - Competitive Landscape, 2026

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Anti-CD20 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD20 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Interleukin 1 Beta Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 1 Beta Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Complement C5 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C5 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Loading Indicator